Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Fatima Alali
King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
113
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Investigations on drug targetable gene mutations in blast crisis chronic myeloid leukemia and their possible implication in drug repurposing for drug-resistant advanced phase CML
Number of pages: 15
Posted: 09 May 2024
Nawaf Alanzazi
,
Batool Salman Alnajad
, Fatima Alali,
Anwar Al-rasasi
,
Kanza
,
Sahar Al-hakeem
,
Sarah Al-Mukhaylid
and
Dr. Zafar Iqbal
King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs
Downloads
113
(626,371)
View PDF
Download
Abstract:
Chronic Myeloid Leukemia, Blast Crisis, druggable gene mutations, drug repurposing, BC-CML survival
Feedback